Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.

Nabeshima S, Kashiwagi K, Ajisaka K, Masui S, Takeoka H, Ikematsu H, Kashiwagi S.

J Infect Chemother. 2012 Aug;18(4):534-43. doi: 10.1007/s10156-012-0378-7.

PMID:
22350323
2.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

PMID:
19911968
3.

Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.

Shobugawa Y, Saito R, Sato I, Kawashima T, Dapat C, Dapat IC, Kondo H, Suzuki Y, Saito K, Suzuki H.

J Infect Chemother. 2012 Dec;18(6):858-64. doi: 10.1007/s10156-012-0428-1.

PMID:
22644080
4.

Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.

Toriumi Y, Kamei T, Murata K, Takahashi I, Suzuki N, Mazda O.

Forsch Komplementmed. 2012;19(4):179-86. doi: 10.1159/000341547.

PMID:
22964983
5.

Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.

Kawai N, Ikematsu H, Tanaka O, Matsuura S, Maeda T, Yamauchi S, Hirotsu N, Nishimura M, Iwaki N, Kashiwagi S.

J Infect Chemother. 2011 Jun;17(3):375-81. doi: 10.1007/s10156-010-0179-9.

PMID:
21120678
6.

Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.

Kawai N, Ikematsu H, Kawashima T, Maeda T, Ukai H, Hirotsu N, Iwaki N, Kashiwagi S.

Influenza Other Respir Viruses. 2013 May;7(3):448-55. doi: 10.1111/j.1750-2659.2012.00421.x.

7.

Neuraminidase inhibitors for preventing and treating influenza in children.

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD002744. doi: 10.1002/14651858.CD002744.pub3. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD002744.

PMID:
22258949
8.

Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.

Carrat F, Duval X, Tubach F, Mosnier A, Van der Werf S, Tibi A, Blanchon T, Leport C, Flahault A, Mentré F; BIVIR study group..

Antivir Ther. 2012;17(6):1085-90. doi: 10.3851/IMP2128.

PMID:
22910171
9.

Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009).

Miyachi K, Watanabe A, Iida H, Hattori H, Ukai H, Takano T, Hankins RW.

J Infect Chemother. 2011 Aug;17(4):524-9. doi: 10.1007/s10156-011-0217-2.

PMID:
21360013
10.

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.

Ikematsu H, Kawai N.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Review.

PMID:
21973296
11.

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial.

Fry AM, Goswami D, Nahar K, Sharmin AT, Rahman M, Gubareva L, Azim T, Bresee J, Luby SP, Brooks WA.

Lancet Infect Dis. 2014 Feb;14(2):109-18. doi: 10.1016/S1473-3099(13)70267-6.

PMID:
24268590
12.

Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitor.

Sugaya N, Sakai-Tagawa Y, Bamba M, Yasuhara R, Yamazaki M, Kawakami C, Yamaguchi Y, Ide Y, Ichikawa M, Mitamura K, Kawaoka Y.

Antivir Ther. 2015;20(1):49-55. doi: 10.3851/IMP2798.

PMID:
24832015
13.
14.

Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K.

Clin Infect Dis. 2008 Aug 1;47(3):339-45. doi: 10.1086/589748.

PMID:
18582202
15.
16.

Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).

Ohnishi K, Nakamura-Uchiyama F.

J Infect Chemother. 2010 Feb;16(1):62-3. doi: 10.1007/s10156-009-0006-3.

PMID:
20072797
17.

Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).

Wang K, Shun-Shin M, Gill P, Perera R, Harnden A.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD002744. doi: 10.1002/14651858.CD002744.pub4. Review.

PMID:
22513907
18.

[Neuraminidase inhibitors and risk of H5N1 influenza].

Gras-Masse H, Willand N.

Ann Pharm Fr. 2007 Jan;65(1):50-7. Review. French.

PMID:
17299351
19.

Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial.

Wang C, Cao B, Liu QQ, Zou ZQ, Liang ZA, Gu L, Dong JP, Liang LR, Li XW, Hu K, He XS, Sun YH, An Y, Yang T, Cao ZX, Guo YM, Wen XM, Wang YG, Liu YL, Jiang LD.

Ann Intern Med. 2011 Aug 16;155(4):217-25. doi: 10.7326/0003-4819-155-4-201108160-00005. Erratum in: Ann Intern Med. 2012 Jan 3;156(1 Pt 1):71.

PMID:
21844547
20.

Neuraminidase inhibitors for preventing and treating influenza in healthy adults.

Jefferson T, Jones M, Doshi P, Del Mar C, Dooley L, Foxlee R.

Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001265. doi: 10.1002/14651858.CD001265.pub3. Review.

PMID:
20166059

Supplemental Content

Support Center